Rare Endocrine Exchange: Why This Conversation Matters @checkrare
Rare Endocrine Exchange: Why This Conversation Matters  @checkrare
Uploaded August 2026 | Updated November 2026, 2 days ago
Rare endocrine disorders can be difficult to recognize, challenging to diagnose, and even harder for patients to navigate. For many patients, the journey to an accurate diagnosis can take years.

Rare Endocrine Exchange, a new podcast from CheckRare, aims to change that.
Hosted by clinical endocrinologist Margarita Ochoa-Maya, MD, the series brings together physicians, researchers, patients, advocates, and other leaders across the rare endocrine community to explore the science, challenges, and real-world experiences behind these disorders.

In this inaugural episode, Dr. Ochoa-Maya introduces the Rare Endocrine Exchange and discusses why greater awareness and collaboration are needed across rare endocrine diseases. Future episodes will explore some of the most important issues facing the community, including:

• Why are rare endocrine disorders diagnosed so slowly?
• Can AI help (or hurt) rare endocrine care?
• What do new guidelines mean for patients with rare endocrine diseases?
• The latest research and clinical advances
• Patient and caregiver experiences
• Advocacy and access to care
• Emerging treatments and clinical trialsThe goal is simple: to create a place where the rare endocrine community can learn from one another.

Whether the conversation is with a leading researcher, a practicing clinician, a patient, or an advocate working to change the system, Dr. Ochoa-Maya will explore the issues that matter most to the people living with and caring for rare endocrine disorders.

This is the Rare Endocrine Exchange.
Rare Endocrine Exchange: Why This Conversation MattersNew Stem Cell Method Could Advance Research Into Spinal Muscular AtrophyImprovements in Mobility in Patients Treated with Miv-Cel with Stiff Person SyndromeUCB Study Highlights the Burden of Ocular Myasthenia GravisNarcolepsy Diagnosis and Symptoms: Understanding the Daily Burden of the DiseaseLiving With Ocular Symptoms of Myasthenia GravisNew Graves’ Disease Community WebsiteFDA Approves Multiple Myeloma Drug;  FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-W...FDA CDER’s Accelerating Rare Disease Cures ProgramSeronegative Myasthenia Gravis Targeted Therapy SelectionFDA Approves New Narcolepsy Treatment | The CheckRare BriefHow Bispecific Antibodies Are Changing Multiple Myeloma Treatment
CheckRare |

Rare Endocrine Exchange: Why This Conversation Matters

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER